Factors associated with suitability of empiric antibiotic therapy in hospitalized patients with bloodstream infections

References

• Renaud B, Brun-Buisson C, Group IC-BS. Outcomes of primary and catheter-related bacteremia: a cohort and case-control study in critically ill patients. Am J Respir Crit Care Med. 2001;163(7):1584–90.10.1164/ajrccm.163.7.9912080
   PubMed Web of Science ®Google Scholar
• Bates DW, Pruess KE, Lee TH. How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia. Arch Intern Med. 1995;155(6):593–8.10.1001/archinte.1995.00430060050006
   PubMedGoogle Scholar
• Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO. Bloodstream infections at a Norwegian University Hospital, 1974–1979 and 1988–1989: changing etiology, clinical features, and outcome. Clin Infect Dis. 1994;19(2):246–56.10.1093/clinids/19.2.246
   PubMed Web of Science ®Google Scholar
• Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244(5):379–86.10.1046/j.1365-2796.1998.00379.x
   PubMed Web of Science ®Google Scholar
• Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115(7):529–35.10.1016/j.amjmed.2003.07.005
   PubMed Web of Science ®Google Scholar
• Salomao R, Castelo Filho A, Pignatari AC, Wey SB. Nosocomial and community acquired bacteremia: variables associated with outcomes. Rev Paul Med. 1993;111(6):456–61.
   PubMedGoogle Scholar
• Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118(1):146–55.10.1378/chest.118.1.146
   PubMed Web of Science ®Google Scholar
• Leone M, Bourgoin A, Cambon S, Dubuc M, Albanèse J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med. 2003;31(2):462–7.10.1097/01.CCM.0000050298.59549.4A
   PubMed Web of Science ®Google Scholar
• MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4):638–56.10.1128/CMR.18.4.638-656.2005
   PubMed Web of Science ®Google Scholar
• Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128–40.10.1016/0196-6553(88)90053-3
   PubMed Web of Science ®Google Scholar
• American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care. 2005;171(4):388–416.
   PubMed Web of Science ®Google Scholar
• Lee CC, Lin WJ, Shih HI, Wu CJ, Chen PL, Lee HC, et al. Clinical significance of potential contaminants in blood cultures among patients in a medical center. J Microbiol Immunol Infect. 2007;40(5):438–44.
   PubMedGoogle Scholar
• Schellevis FG, van der Velden J, van de Lisdonk E, van Eijk JT, van Weel C. Comorbidity of chronic diseases in general practice. J Clin Epidemiol. 1993;46(5):469–73.10.1016/0895-4356(93)90024-U
   PubMed Web of Science ®Google Scholar
• Angkasekwinai N, Rattanaumpawan P, Thamlikitkul V. Epidemiology of sepsis in Siriraj Hospital 2007. J Med Assoc Thai. 2009;92 Suppl 2:S68–78.
   PubMedGoogle Scholar
• Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136(5):1237–48.10.1378/chest.09-0087
   PubMed Web of Science ®Google Scholar
• Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsberger H, et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother. 1997;41(5):1127–33.
   PubMed Web of Science ®Google Scholar
• Behrendt G, Schneider S, Brodt HR, Just-Nübling G, Shah PM. Influence of antimicrobial treatment on mortality in septicemia. J Chemother. 1999;11(3):179–86.10.1179/joc.1999.11.3.179
   PubMed Web of Science ®Google Scholar
• Zaragoza R, Artero A, Camarena JJ, Sancho S, González R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect. 2003;9(5):412–8.10.1046/j.1469-0691.2003.00656.x
   PubMed Web of Science ®Google Scholar
• Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic‐resistant gram‐negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis. 2002;34(12):1600–6.10.1086/cid.2002.34.issue-12
   PubMed Web of Science ®Google Scholar
• Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54(11):4851–63.10.1128/AAC.00627-10
   PubMed Web of Science ®Google Scholar
• Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36(11):1418–23.10.1086/375057
   PubMed Web of Science ®Google Scholar
• Shorr AF, Micek ST, Welch EC, Doherty JA, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med. 2011;39(1):46–51.10.1097/CCM.0b013e3181fa41a7
   PubMed Web of Science ®Google Scholar
• Reisfeld S, Paul M, Gottesman BS, Shitrit P, Leibovici L, Chowers M. The effect of empiric antibiotic therapy on mortality in debilitated patients with dementia. Eur J Clin Microbiol Infect Dis. 2011;30(6):813–8.10.1007/s10096-011-1161-x
   PubMed Web of Science ®Google Scholar
• Cortes JA, Garzon DC, Navarrete JA, Contreras KM. Impact of inappropriate antimicrobial therapy on patients with bacteremia in intensive care units and resistance patterns in Latin America. Rev Argent Microbiol. 2010;42(3):230–4.
   PubMed Web of Science ®Google Scholar
• Permpikul C, Tongyoo S, Ratanarat R, Wilachone W, Poompichet A. Impact of septic shock hemodynamic resuscitation guidelines on rapid early volume replacement and reduced mortality. J Med Assoc Thai. 2010;93 Suppl 1:S102–9.
   Google Scholar
• Lueangarun S, Leelarasamee A. Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: a retrospective study. Interdiscip Perspect Infect Dis. 2012; 765205.
   PubMedGoogle Scholar
• Leibovici L, Greenshtain S, Cohen O, Mor F, Wysenbeek AJ. Bacteremia in febrile patients: a clinical model for diagnosis. Arch Intern Med. 1991;151(9):1801–6.10.1001/archinte.1991.00400090089016
   PubMedGoogle Scholar
• Lee CC, Chang CM, Hong MY, Hsu HC, Ko WC. Different impact of the appropriateness of empirical antibiotics for bacteremia among younger adults and the elderly in the ED. Am J Emerg Med. 2013;31(2):282–90.10.1016/j.ajem.2012.07.024
   PubMed Web of Science ®Google Scholar
• Diamantis S, Rioux C, Bonnal C, Farfour É, Papy E, Andremont A, et al. Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it. Eur J Clin Microbiol Infect Dis. 2012;31(7):1667–71.10.1007/s10096-011-1491-8
   PubMed Web of Science ®Google Scholar
• Lee CC, Lee CH, Chuang MC, Hong MY, Hsu HC, Ko WC. Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED. Am J Emerg Med. 2012;30(8):1447–56.10.1016/j.ajem.2011.11.010
   PubMed Web of Science ®Google Scholar
• Classen DC, Burke JP, Wenzel RP. Infectious diseases consultation: impact on outcomes for hospitalized patients and results of a preliminary study. Clin Infect Dis. 1997;24(3):468–70.10.1093/clinids/24.3.468
   PubMed Web of Science ®Google Scholar
• Martinez JA, Cobos-Trigueros N, Soriano A, Almela M, Ortega M, Marco F, et al. Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms. Antimicrob Agents Chemother. 2010;54(9):3590–6.10.1128/AAC.00115-10
   PubMed Web of Science ®Google Scholar
• Micek ST, Welch EC, Khan J, Pervez M, Doherty JA, Reichley RM, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother. 2010;54(5):1742–8.10.1128/AAC.01365-09
   PubMed Web of Science ®Google Scholar